在与惰的B细胞克隆相关的自身免疫细胞衰竭中,与前线利图西马布的持久反应
Yoann Zadro1, Amélie Lusque2, Héloïse Rey3
1Department of Internal Medicine, IUCT-Oncopole-Toulouse University Hospital, Toulouse University, Toulouse, France.
American journal of hematology
|July 8, 2025
概括
最前沿的Rituximab为与惰的B细胞克隆相关的自身免疫细胞衰竭提供了持久的反应. 这种治疗为这些罕见疾病提供了有前途的治疗策略.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 自身免疫细胞衰竭 (AIC) 可能与惰的B细胞淋巴细胞恶性瘤有关.
- 抗CD20单克隆抗体利图西马布是各种B细胞疾病的标准治疗方法.
更多相关视频
09:54Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
Published on: May 22, 2020
3.6K
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.5K
相关概念视频
Cells of the Adaptive Immune Response
4.5K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
4.5K
B Cell Activation and Differentiation
6.5K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
6.5K
Cell-mediated Immune Responses
73.5K
Overview
73.5K
